Racheli Ofir
Chief Executive Officer presso Betalin Therapeutics Ltd.
Profilo
Racheli Ofir is currently the Co-Chief Executive and Chief Technology Officer at Betalin Therapeutics Ltd.
Prior to this, she worked at Pluri, Inc. as the Vice President of Data and Intellectual Property from 2007 to 2022.
She holds a doctorate degree from both Technion-Israel Institute of Technology and Israel Institute of Technology.
Posizioni attive di Racheli Ofir
| Società | Posizione | Inizio |
|---|---|---|
Betalin Therapeutics Ltd.
 Betalin Therapeutics Ltd. Packaged SoftwareTechnology Services Betalin Therapeutics Ltd. develops micro-pancreas and cell technology. The company is based in Jerusalem, Israel. The CEOs are Racheli Ofir, Moti Friedman. The Israeli company was founded in 2015 by Shuki Hershcovich. | Chief Executive Officer | 01/12/2022 |
Precedenti posizioni note di Racheli Ofir
| Società | Posizione | Fine |
|---|---|---|
| PLURI INC. | Chief Tech/Sci/R&D Officer | 01/05/2022 |
Formazione di Racheli Ofir
| Technion-Israel Institute of Technology | Doctorate Degree |
| Israel Institute of Technology | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| PLURI INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Betalin Therapeutics Ltd.
Betalin Therapeutics Ltd. Packaged SoftwareTechnology Services Betalin Therapeutics Ltd. develops micro-pancreas and cell technology. The company is based in Jerusalem, Israel. The CEOs are Racheli Ofir, Moti Friedman. The Israeli company was founded in 2015 by Shuki Hershcovich. | Technology Services |
- Borsa valori
- Insiders
- Racheli Ofir
